Company intelligence / Profile preview

SterileCare

Markham, Ontario, Canadasterilecareinc.com ↗

Ownership: Private
Development stage: Commercial

Overview

SterileCare’s lead product KiteLock 4% is a non-antibiotic catheter lock solution clinically proven to reduce central line-associated bloodstream infections and catheter occlusions by over 70%. It is the only globally approved lock solution safe enough for children. A pivotal clinical trial is ongoing at Cincinnati Children’s Hospital to evaluate its safety and effectiveness versus standard heparin locks in preventing CVC occlusions among pediatric patients with intestinal failure. As of January 2025, the study had enrolled 20 of a planned 124 participants

Therapeutic areas: Infectious DiseasesHematology
Modalities: DeviceNon-pharmacological therapy (catheter lock solution)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

KiteLock 4%

Commercial

Indications: Catheter-related bloodstream infections, Catheter occlusions

Partnerships

dicentra (Contract Research Organization supporting clinical trials)

Beyond the preview

Go deeper on SterileCare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SterileCare.